Eagle Strategies LLC

Position in ABBV — AbbVie Inc.

CIK 1907666 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$820,849

+$366,295 QoQ

Shares Held

3,262

+56.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#2,735

of 4,153 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eagle Strategies LLC holds $8,022,452 across 6 Drug Manufacturers - General names. ABBV ranks #3 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,271	$5,122,765
2	JNJ	Johnson & Johnson	3,678	$934,101
3	ABBV	AbbVie Inc. This page	3,262	$820,849
4	NVS	Novartis AG	2,616	$409,979
5	GILD	Gilead Sciences, Inc.	3,232	$408,330
6	PFE	Pfizer Inc	13,556	$326,428

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$820,849	3,262	+56.1%	Shares	Sole	2026-07-21
2026-03-31	$454,554	2,090	+25.4%	Shares	Sole	2026-04-20
2025-12-31	$380,892	1,667	+0.8%	Shares	Sole	2026-01-23
2025-09-30	$382,735	1,653	-4.7%	Shares	Sole	2025-10-21
2025-06-30	$321,865	1,734	-1.6%	Shares	Sole	2025-07-23
2025-03-31	$369,383	1,763	-0.2%	Shares	Sole	2025-04-23
2024-12-31	$313,995	1,767	-4.0%	Shares	Sole	2025-02-14
2024-09-30	$363,363	1,840	-2.5%	Shares	Sole	2024-10-25
2024-06-30	$323,658	1,887	-83.6%	Shares	Sole	2024-08-08
2024-03-31	$2,094,878	11,504	+496.1%	Shares	Sole	2024-04-23
2023-12-31	$299,092	1,930	+1.0%	Shares	Sole	2024-01-26
2023-09-30	$284,704	1,910	-23.6%	Shares	Sole	2023-11-08
2023-06-30	$336,825	2,500	+0.0%	Shares	Sole	2023-08-03
2023-03-31	$398,265	2,499	+7.4%	Shares	Sole	2023-04-24
2022-12-31	$375,904	2,326	+14.2%	Shares	Sole	2023-02-06
2022-09-30	$273,251	2,036	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.